Search for Clinical Trial Results
Becker Muscular Dystrophy - 196 Studies Found
Status | Study |
Withdrawn |
Study Name: Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2012-05-21 Interventions: Biological: human umbilical cord mesenchymal stem cells rehabilitation therapy plus human umbilical cord |
Recruiting |
Study Name: An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Condition: Duchenne Muscular Dystrophy Date: 2016-04-28 Interventions:
|
Recruiting |
Study Name: A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Condition: Duchenne Muscular Dystrophy Date: 2016-04-28 Interventions:
|
Enrolling by invitation |
Study Name: Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Condition: Duchenne Muscular Dystrophy Date: 2017-01-30 Interventions:
|
Active, not recruiting |
Study Name: Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients Condition: Duchenne Muscular Dystrophy Date: 2015-08-10 Interventions:
|
Completed |
Study Name: Stem Cell Therapy in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2014-09-12 Interventions: Biological: Stem Cell Intrathecal autologous bone marrow mononuclear cell transplantation |
Completed |
Study Name: Safety Study of Flavocoxid in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2011-04-12 Interventions: Drug: Flavocoxid Flavocoxid capsules TTD 500 mg/die or 1000 mg/die for 1 year |
Active, not recruiting |
Study Name: Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2010-08-17 Interventions:
|
Completed |
Study Name: Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2012-01-26 Interventions:
|
Recruiting |
Study Name: Study of DS-5141b in Patients With Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2016-01-26 Interventions: Drug: DS-5141b DS-5141b, Subcutaneous injection |